[ET Net News Agency, 7 July 2021] SSY Group Limited (02005) said Shijiazhuang No. 4
Pharmaceutical Co., Ltd. (Shijiazhuang No. 4 Pharma, a wholly-owned subsidiary of the
company) and China Pharmaceutical University (Party B) have entered into the cooperation
agreement in relation to establishing joint laboratory together with its supplemental
agreement.
Both parties have agreed to use their respective qualifications in hardware or expertise
in fields of personnel, funds, and technology to establish a school-enterprise joint
laboratory and to build up a long-term and stable cooperation relationship in various
fields such as new drug research and development. (RC)